Allergy diagnostic and companion test for specific immunotherapy control
Allergic diseases are ranked fourth by the WHO and many allergy specialists believe that in less than 10 years one person out of two will be diagnosed as allergic. In France it is estimated that one third of the population was affected by allergies in 2010. In 1980 the prevalence was only 10%. The United-States shows a 55% of all U.S. citizens who have been diagnosed positive for at least one allergen. Allergies are the sixth cause of chronic disease in the United-States and cost more than $18 billion to the health system every year . Yet, more than 50% of allergic are not diagnosed as such and do not benefit from appropriate treatment.
AXO Science developed the HIFI Allergy platform
HIFI Allergy is a fully robotized high-throughput allergen screening platform. Its flexible design allow to develop fully customized microarray with any kind of allergens.
HIFI Allergy was used by Stallergenes in the scientific article “Patterns of IgE sensitization in house dust mite-allergic patients: implications for allergen immunotherapy”. Results have proven the reliability and performance of AXO Science fully robotized HIFI Allergy platform. It answers accuracy requirements and has opened the door to a new way of treating allergic patients worldwide.
Continue reading Patterns of IgE sensitization in house dust mite-allergic patients: implications for allergen immunotherapy, published in European Journal of Allergy and Clinical Immunology.